GlobeNewsWire
10 Nov 2025, 15:51 UTC · 45w ago
Verdict
Headline takes no side. We score MRUS +0.40 — moderately bullish.
+0.40moderately bullish
More positive than 63% of ticker scores this week
Which stocks this story touches
More positive than 63% of ticker scores this week
The company is being acquired by Genmab, which typically implies a premium for shareholders.
More positive than 46% of ticker scores this week
The company is securing significant funding through notes and loans to facilitate the acquisition of Merus.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More positive than 95% of relationship scores this week
[a_to_b] Genmab is in the process of the pending acquisition of Merus N.V.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
5h ago
−5.5%
Price is moving against the score
$90.00 vs $95.23 close before publication (Nov 7) · not market-adjusted
MRUS chart →
